Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIST with fludarabine and busulfan for hematological malignancies
NCT00619645Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jun 2007
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), sponsored by University of California, Davis. Started Jun 2007; status: completed.
02
Drugs
fludarabinebusulfan
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)chronic lymphocytic leukemia (CLL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00619645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619645.